Hsiao Lieu
Director Técnico/Científico/I+D en NGM BIOPHARMACEUTICALS, INC. .
Fortuna: 55 499 $ al 31/03/2024
Cargos activos de Hsiao Lieu
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| NGM BIOPHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 01/03/2019 | - |
| The University of California, San Francisco | Corporate Officer/Principal | - | - |
Historial de carrera de Hsiao Lieu
Antiguos cargos conocidos de Hsiao Lieu.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/11/2017 | 01/03/2019 |
| PORTOLA PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 01/01/2008 | 01/01/2008 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Director Técnico/Científico/I+D | 01/01/2006 | 01/01/2006 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - | - |
| Retinorx LLC | Director Ejecutivo | - | - |
| Fundador | - | - | |
| CAPRICOR THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 01/03/2008 | - |
Formación de Hsiao Lieu.
| New York University | Undergraduate Degree |
| Yeshiva University | Doctorate Degree |
| Albert Einstein College of Medicine, Inc. | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 12 |
Operativa
| Chief Tech/Sci/R&D Officer | 4 |
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 2 |
Sectorial
| Health Technology | 7 |
| Consumer Services | 5 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| CAPRICOR THERAPEUTICS, INC. | Health Technology |
| NGM BIOPHARMACEUTICALS, INC. | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
| Empresas privadas | 4 |
|---|---|
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
| Retinorx LLC | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Hsiao Lieu
- Experiencia
